Literature DB >> 12467764

Current and future hepatitis C virus diagnostic testing: problems and advancements.

Ayaz M Majid1, David R Gretch.   

Abstract

Serological antibody assays used in hepatitis C virus diagnosis have improved in sensitivity and specificity. However, detection of active viremia or monitoring levels of virus during or after patient treatment is most commonly undertaken using nucleic acid-based technologies. Advancements in diagnostic technologies and implications for managing patients with hepatitis C in various clinical settings are discussed.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12467764     DOI： 10.1016/s1286-4579(02)01650-7

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  9 in total

1.  Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle.

Authors:  Ayaz M Majid; Heather Ezelle; Sangeeta Shah; Glen N Barber
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Combined effects of alcohol and hepatitis C: a secondary analysis of alcohol use biomarkers and high-risk behaviors from two medication trials for alcohol dependence.

Authors:  Jennifer G Plebani; Carlos F Tirado; Helen M Pettinati; Kyle M Kampman; Joseph R Volpicelli; David W Oslin
Journal:  Addict Behav       Date:  2009-09-10       Impact factor: 3.913

3.  Detection and quantification of hepatitis C virus (HCV) by MultiCode-RTx real-time PCR targeting the HCV 3' untranslated region.

Authors:  Elizabeth K Mulligan; J J Germer; Max Q Arens; Krista L D'Amore; Adrian Di Bisceglie; Nathan A Ledeboer; Michael J Moser; Andrew C Newman; Andy K O'Guin; Paul D Olivo; Diane S Podzorski; Kimberly A Vaughan; Joseph D Yao; Slava A Elagin; Scott C Johnson
Journal:  J Clin Microbiol       Date:  2009-06-17       Impact factor: 5.948

4.  Comparison of performance characteristics of three real-time reverse transcription-PCR test systems for detection and quantification of hepatitis C virus.

Authors:  M Fernanda Sábato; Mitchell L Shiffman; Michael R Langley; David S Wilkinson; Andrea Ferreira-Gonzalez
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

5.  HCV genetics and genotypes dictate future antiviral strategies.

Authors:  Louis Papageorgiou; Chrisanthy Vlachakis; Konstantina Dragoumani; Sofia Raftopoulou; Dimitrios Brouzas; Nicolas C Nicolaides; George P Chrousos; Evangelia Charmandari; Vasileios Megalooikonomou; Dimitrios Vlachakis
Journal:  J Mol Biochem       Date:  2017-12-10

6.  Zeptomole detection of a viral nucleic acid using a target-activated ribozyme.

Authors:  Narendra K Vaish; Vasant R Jadhav; Karl Kossen; Christopher Pasko; Lori E Andrews; James A McSwiggen; Barry Polisky; Scott D Seiwert
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

7.  Demonstration of hepatitis C virus RNA with in situ hybridization employing a locked nucleic Acid probe in humanized liver of infected chimeric mice and in needle-biopsied human liver.

Authors:  Kazuya Shiogama; Ken-Ichi Inada; Michinori Kohara; Hidemi Teramoto; Yasuyoshi Mizutani; Takanori Onouchi; Yutaka Tsutsumi
Journal:  Int J Hepatol       Date:  2013-06-18

8.  The Usefulness of Anti-HCV Signal to Cut-off Ratio in Predicting Viremia in Anti-HCV in Patients With Hepatitis C Virus Infection.

Authors:  Fahimeh Ranjbar Kermani; Zohreh Sharifi; Fereshteh Ferdowsian; Zahrah Paz; Farzaneh Tavassoli
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

9.  Poisoned patients as potential organ donors: postal survey of transplant centres and intensive care units.

Authors:  David Michael Wood; Paul Ivor Dargan; Alison Linda Jones
Journal:  Crit Care       Date:  2003-03-06       Impact factor: 9.097
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.